Portage Biotech
Road Town, Tortola, D8 · Artificial Intelligence, Blockchain, Cryptocurrency · 35 employees
Portage Biotech is clinical stage biopharmaceutical company driving the development of first-in-class immuno-oncology therapies to help more patients achieve durable treatment responses and a better quality of life. The Company is using its strong industry network and diverse drug platforms to identify novel assets and asset combinations.
Funding history
- Series seed — $2.0M — May 2026
- Funding Round — $36.1M — Sep 2025
- Funding Round — $1 — Oct 2023
Recent signals
- May 29, 2026: Raised $2.0M in Series seed
- Apr 24, 2026: Acquired Alpha Compute to acquire 60% stake in GAMEE
- Apr 24, 2026: Acquired Alpha Compute to acquire 60% of GAMEE
- Apr 24, 2026: Acquired Alpha Compute to acquire 60% of GAMEE in May 2026
- Mar 19, 2026: Acquired AlphaTON Capital acquires majority stake in GAMEE
- Mar 19, 2026: Acquired AlphaTON Capital acquires 60% of GAMEE
- Oct 23, 2025: AlphaTON Capital Corp Appoints Wes Levitt as Chief Financial Officer
- Oct 22, 2025: AlphaTON Capital Partners with Blockchain Game Alliance to Enhance Telegram Gaming Experience
See plans & pricing → Track Portage Biotech’s funding, hiring, and signals — with verified contacts — on Fundz.